About PharmaResources

PharmaResources, established in 2007, is a comprehensive one-stop service provider for new drug R&D as well as commercial production. We are dedicated to the drug discovery,pharmaceutical processes R&D, and the commercial manufacturing of APIs and intermediates.

Scroll down to browse

About PharmaResources

PharmaResources, established in 2007, is a comprehensive one-stop service provider for new drug R&D as well as commercial production. We are dedicated to the drug discovery, pharmaceutical processes R&D, and the commercial manufacturing of APIs and intermediates.

Our new drug R&D services cover the entire process of preclinical new drug research, primarily including drug discovery and processR&D. In drug discovery, we assist clients in designing, screening, and optimizing hit compounds and lead compounds , conducting structural improvements, and preliminary safety screening to obtain candidate compounds with outstanding drug properties and intellectual property rights.In our process R&D servicewe provide new drug process chemistry services and innovative synthetic process development for global pharmaceutical companies,helping clients to achieve cost-effective, safe, green, and reliable commercial manufacturing of intermediates and APIs in scales from kilograms to tons. Leveraging our technological advantages in pharmaceutical process technology, we also engage in the customized manufacturing services of key drug intermediates,as well as independent research and development and manufacturing of specialty APIs intermediates with complex chemical structures and high synthesis difficulties.

In March 2021, PharmaResources' IPO application for GEM was accepted by the Shenzhen Stock Exchange. In April 2022, it successfully passed the review of the Listing Committee of the Shenzhen Stock Exchange.On July 8, 2022, the China Securities Regulatory Commission approved the application of PharmaResources (Shanghai) Co.,Ltd. for an initial public offering of stocks and listing on the Shenzhen GEM. On October 18, 2022, PharmaResources issued 19.25 million A-shares in its initial public offering and was listed on the GEM.

As advocated in the core values of PharmaResources, 'Science-driven, continuous innovation'.Regardless of how the internal and external environment may change, 'Science and Innovation' is the perpetual goals of our team. Only by consistently pursuing scientific excellence and technological innovation can we meet the ever-changing needs of our clients and the market, while ensuring the sustainable competitiveness of our company.

Company Locations

Location
PharmaResources provides global pharmaceutical clients with one-stop services in the R&D and manufacturing of small molecule innovative drugs.

Services

  • Drug
    discovery
  • Process
    discovery
  • Pharmaceutical
    study
  • Drug
    production

    Founder Team

    Team of founders

    Chen PingPhD

    / General Manager, Chairman, Founder of PharmaResources (Shanghai)

    Bachelor of Science, Peking University; PhD, Duke University; Postdoctoral Fellow, University of Montreal, Canada

    Senior principal Scientist of Bristol-Myers Squibb (17 years), principal inventor of dasatinib, a new drug for chronic myeloid leukemia

    Laureate of the “Thomas A. Edison Patent Award” granted by the Research & Development Council of New Jersey in 2008

    Published 40+ SCI scientific papers and filed ~35 PCT invention patents (including 28 granted)

    Expert of the 6th “National Thousand Talents Plan”, member of the Major Science and Technology Project Committee for the 2017 “Major New Drug Creation”of the National Health Commission of the People’s Republic of China

    Jiang ShengliEMBA

    / / Director/Secretary to the Board, Deputy General Manager, Founder of PharmaResources (Shanghai)

    Bachelor of Science, Sichuan University, MBA from China Europe International Business School

    Previous technical and managerial positions include engineer, chief engineer, general manager in several pharmaceutical companies, with extensive experience in process development and production scale-up

    Laureate of the first prize of Science and Technology Award of Zhejiang Province in 2002 and the third prize of Science and Technology Award of Zhejiang Province in 2003

    Filed 8 invention patents (including 4 granted patents)

    An Rongchang

    / Director, Founder of PharmaResources (Kaiyuan)

    Bachelor of Science, Fudan University, MBA, Suffolk University, Boston, USA (in progress)

    34 years of working experience in the industry including Northeast Pharmaceutical General Factory and Shenyang Dongyu Chemical Co., Ltd.

    Founder of Kaiyuan Hengtai Nutrition Co., Ltd.

    Founder of Zhejiang Anglitai Pharmaceutical Manufacturing Co., Ltd.

    1 / 3
    • Chen PingPhD
    • Jiang ShengliEMBA
    • An Rongchang

    Core management team

    Core management team
    • Cai Zhenwei PhD

      Executive Vice President / Medicinal Chemistry

      Rutgers University, USA

      PhD in Medicinal Chemistry
      30 years of working experience
    • Xu Zhongmin

      Senior Vice President / Process Development

      Boston College, USA

      PhD in Organic Chemistry
      30 years of working experience
    • Li Haifeng MS

      Deputy General Manager / EHS

      Fudan University

      Master of Chemical Engineering
      21 years of working experience
    • Zhang Yuan MS

      Vice President/Business Development

      University of Frankfurt, Germany

      Master of Science in Biology
      23 years of working experience
    • Li Shicheng BS

      Chief Financial Officer

      Shanghai University of Finance and Economics

      Bachelor of Science in Accounting
      20 years of working experience
    • Tang Kaiyong PhD

      Vice President / Pharmaceutical Research

      East China Normal University

      PhD in Organic Chemistry
      16 years of working experience
    • Li Juan PhD

      Executive Deputy General Manager
      Kaiyuan PharmaResources (Factory)

      Shenyang Pharmaceutical University

      PhD in Medicinal Chemistry
      16 years of working experience

    Milestones

    Development course

    Honors and Awards

    Enterprise honor

    Partners

    Cooperative partner

    Corporate Culture

    Enterprise culture
    • Our Mission

      To support drug discovery and benefit human health

    • Our Vision

      To build a one-stop integrated service platform for drug development and production

    • Our Values

      Science-focused, continuous innovation, integrity and efficiency, cooperation and dedication

    • Address

      Bldg. 12, No. 59 Kai Qing Rd, Pudong, Shanghai (West Campus)

      Bldg. 7, No. 509 Ren Qing Rd, Pudong, Shanghai (East Campus)

    • Investment Contact

      +86-21-50720228-202

    • Email

      sales@pharmaresources.cn

      Will reply as soon as possible.

    Copyright © Copyright 2024 PharmaResources (Shanghai) Co., Ltd. (Official Website)

    Reference No: Shanghai ICP 20013779 Website Constructed by:Ocean Design, Shanghai